This interaction not only provides what we believe are new insights into the molecular mechanisms of ANO5 in bone formation, but also provides preliminary insights into the pathogenesis of GDD and its potential therapeutic targets. Here, ANO5 is linked to gnathodiaphyseal dysplasia.